Nachman Norwood & Parrott’s Pfizer PFE Stock Holding History

Nachman Norwood & Parrott’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3.66M	Sell	93,435 -1,684	-2%	-$65.5K	0.37%	51
2021 Q1	$3.45M	Buy	95,119 +11,147	+13%	+$396K	0.38%	54
2020 Q4	$3.09M	Buy	83,972 +2,676	+3%	+$98.2K	0.36%	56
2020 Q3	$2.83M	Sell	81,296 -4,977	-6%	-$174K	0.38%	53
2020 Q2	$2.68M	Sell	86,273 -563	-0.6%	-$19.1K	0.44%	45
2020 Q1	$2.69M	Buy	86,836 +2,696	+3%	+$91.9K	0.54%	38
2019 Q4	$3.13M	Buy	84,140 +1,205	+1%	+$42.9K	0.51%	40
2019 Q3	$2.83M	Sell	82,935 -817	-1%	-$29.7K	0.5%	43
2019 Q2	$3.44M	Buy	83,752 +6,214	+8%	+$247K	0.62%	30
2019 Q1	$3.12M	Sell	77,538 -278	-0.4%	-$11.1K	0.58%	33
2018 Q4	$3.22M	Buy	+77,816	New	+$3.23M	0.67%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nachman Norwood & Parrott's PFE Position: Q2 2021 in Review

Nachman Norwood & Parrott reduced its Pfizer (PFE) stake by 1.8% in Q2 2021, selling an estimated $65.5K and leaving 93,435 shares worth $3.66M. The position accounts for 0.37% of the portfolio, ranked #51.

Nachman Norwood & Parrott first reported a position in PFE in Q4 2018 and has held it in 11 quarters since. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Nachman Norwood & Parrott held 93,435 shares of Pfizer worth $3.66M as of Q2 2021.
Nachman Norwood & Parrott sold 1,684 Pfizer shares in Q2 2021, an estimated $65.5K.
Pfizer made up 0.37% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #51 holding.
Nachman Norwood & Parrott first reported a position in Pfizer in Q4 2018 and has held it in 11 quarters since.
2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.